James Xu Shubi

James Xu has led the Great China region for Corza Medical (and its predecessor entity) for over 7 years. Prior to joining the Company James was the Managing Director of Devicor Medical China. In this role, James was part of the management team that successfully spun off Johnson & Johnson’s breast care business to form Devicor, which was subsequently acquired by Danaher/Leica Biosystems. Prior to Devicor, James worked for Johnson & Johnson Medical China for 15 years, across numerous specialties including cardiovascular, orthopedics and women’s health. James graduated from Second Military Medical University in Shanghai and earned an MBA from Rutgers University School of Business.